Form D — Esanik Therapeutics, Inc.
0002044524-26-000003 · filed 2026-04-30
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $375,000
- Total sold
- $200,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Esanik Therapeutics, Inc.
- CIK
- 2044524
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 120 West Main Street
Northville, MI 48167 - Phone
- 610-725-1500
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John Mel Sorensen · Executive OfficerNorthville, MI Find on LinkedIn ↗
View original on SEC EDGAR.